NCT07706348 clinical trial report covering Ondansetron Hydrochloride, Phase 1/2, endpoints, sponsor, geography, readout timing and development white space.

NCT07704580 clinical trial report covering Sarilumab, Phase 1/2, endpoints, sponsor, geography, readout timing and development white space.

NCT07704866 clinical trial report covering B-901, Phase 1/2, endpoints, sponsor, geography, readout timing and development white space.

NCT07705074 clinical trial report covering [18F]FAPI-74, Phase 1/2, endpoints, sponsor, geography, readout timing and development white space.

NCT07705919 clinical trial report covering Albumin-Bound Paclitaxel, Phase 1/2, endpoints, sponsor, geography, readout timing and development white space.

NCT07708194 clinical trial report covering Pyrotinib Maleate, Phase 1/2, endpoints, sponsor, geography, readout timing and development white space.

NCT07706855 clinical trial report covering GKL-006RTU, Phase 1/2, endpoints, sponsor, geography, readout timing and development white space.

NCT07706959 clinical trial report covering Zeprumetostat, Phase 1/2, endpoints, sponsor, geography, readout timing and development white space.

NCT07708285 clinical trial report covering Serplulimab, Phase 1/2, endpoints, sponsor, geography, readout timing and development white space.

NCT07707895 clinical trial report covering Zocilurtatug Pelitecan, Phase 1/2, endpoints, sponsor, geography, readout timing and development white space.

CTR20262727 clinical trial report covering BY-101921, Phase 1/2, endpoints, sponsor, geography, readout timing and development white space.

NCT07711210 clinical trial report covering ACC-017, Phase 1/2, endpoints, sponsor, geography, readout timing and development white space.